Loading company…
MEDIC Life Sciences develops cancer drugs using genomic analysis and patient tumor-like models.
Founded in 2019 and based in California, US, MEDIC Life Sciences is developing cancer drugs. Its platform combines CRISPR functional genomics with patient tumor-like cancer models to identify potential drug targets. In December 2021, it raised seed funding from Primer Sazze Partners; the terms were not disclosed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in